Picture of Krka dd Novo Mesto logo

KRKG Krka dd Novo Mesto News Story

0.000.00%
si flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Slovenian Krka says depreciation of rouble will hurt 2014 profit

LJUBLJANA, Dec 16 (Reuters) - Slovenia's largest 
pharmaceutical company Krka  KRKG.LJ   KRK.WA  said on Tuesday 
the recent significant depreciation of the Russian rouble was 
likely to dent its earnings this year. 
    "The fall in the value of the Russian rouble has a negative 
impact on the value of Krka group sales in the Russian 
Federation and creates negative currency differences, which has 
a negative impact on Krka's profit," Krka said in a statement 
but gave no figures or estimates. 
    Krka, which sells about a quarter of its output to Russia, 
said in November it expected group next profit this year to be  
level with last year, when it reached 172.8 million euros. 
 ID:nL6N0SW41T  
    Shares of Krka, Slovenia's largest listed company, closed 
1.74 percent lower at 56.6 euros on Tuesday, before the profit 
warning was released, while the blue-chip SBI index  .SBITOP  
lost 1.19 percent. 
 
 (Reporting By Marja Novak; Editing by Zoran Radosavljevic and 
Keith Weir) 
 ((Marja.Novak@thomsonreuters.com; +386-8-205-6369; Reuters 
Messaging: marja.novak.thomsonreuters.com@reuters.net)) 
 
Keywords: KRKA PROFIT/

Recent news on Krka dd Novo Mesto

See all news